|
NARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.468100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.252500E-02 |
| Normal-vs-Stage2 |
6.003900E-02 |
| Normal-vs-Stage3 |
7.536000E-03 |
| Normal-vs-Stage4 |
5.904100E-03 |
| Stage1-vs-Stage2 |
5.228000E-01 |
| Stage1-vs-Stage3 |
1.104830E-01 |
| Stage1-vs-Stage4 |
1.409990E-01 |
| Stage2-vs-Stage3 |
6.281200E-01 |
| Stage2-vs-Stage4 |
5.252200E-01 |
| Stage3-vs-Stage4 |
8.285200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.110200E-02 |
| Normal-vs-AfricanAmerican |
3.862600E-03 |
| Normal-vs-Asian |
1.733750E-02 |
| Caucasian-vs-AfricanAmerican |
5.421700E-02 |
| Caucasian-vs-Asian |
3.260800E-01 |
| AfricanAmerican-vs-Asian |
2.817000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.562600E-03 |
| Normal-vs-Female |
5.843500E-02 |
| Male-vs-Female |
7.644400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.313400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.753740E-02 |
| Normal-vs-Age(61-80Yrs) |
6.822400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.070000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.043830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.866200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.738000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.986400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.605600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.890600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.580800E-01 |
| Classical-VS-Follicular |
7.616800E-03 |
| Classical-VS-Other |
7.011000E-01 |
| Classical-VS-Normal |
1.456410E-01 |
| Tall-VS-Follicular |
2.885800E-01 |
| Tall-VS-Other |
5.806000E-01 |
| Tall-VS-Normal |
1.047550E-01 |
| Follicular-VS-Other |
3.655200E-01 |
| Follicular-VS-Normal |
1.815790E-03 |
| Other-VS-Normal |
9.895800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.541000E-03 |
| Normal-vs-N1 |
7.539200E-03 |
| N0-vs-N1 |
5.861200E-01 |
|
|
